# Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy

> **NCT01236690** · PHASE2 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 284 (estimated)

## Conditions studied

- Hepatoma
- Cinobufacin Injection

## Interventions

- **DRUG:** Cinobufacin injection

## Key facts

- **NCT ID:** NCT01236690
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 284 (ESTIMATED)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01236690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01236690, "Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01236690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*